Antioxidants and oxidations in bronchopulmonary dysplasia: there are no easy answers
- PMID: 14657807
- DOI: 10.1067/S0022-3476(03)00626-7
Antioxidants and oxidations in bronchopulmonary dysplasia: there are no easy answers
Comment on
-
N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: a randomized controlled trial.J Pediatr. 2003 Dec;143(6):713-9. doi: 10.1067/S0022-3476(03)00419-0. J Pediatr. 2003. PMID: 14657813 Clinical Trial.
Similar articles
-
Shielding parenteral nutrition from light: does the available evidence support a randomized, controlled trial?Pediatrics. 2009 Jun;123(6):1529-33. doi: 10.1542/peds.2008-1865. Pediatrics. 2009. PMID: 19482764
-
New strategies for the prevention of bronchopulmonary dysplasia.Clin Perinatol. 1987 Sep;14(3):599-620. Clin Perinatol. 1987. PMID: 3311541 Review.
-
Rationale for antioxidant therapy in premature infants to prevent bronchopulmonary dysplasia.Nutr Rev. 2001 Jan;59(1 Pt 1):10-7. doi: 10.1111/j.1753-4887.2001.tb01899.x. Nutr Rev. 2001. PMID: 11281247 Review.
-
Bronchopulmonary dysplasia.Lancet. 2006 Apr 29;367(9520):1421-31. doi: 10.1016/S0140-6736(06)68615-7. Lancet. 2006. PMID: 16650652 Review.
-
Dietary antioxidants in the prevention of oxygen-induced injury.Semin Perinatol. 1989 Apr;13(2):97-103. Semin Perinatol. 1989. PMID: 2662418 Review. No abstract available.
Cited by
-
Mechanisms of bronchopulmonary dysplasia.J Cell Commun Signal. 2013 Jun;7(2):119-27. doi: 10.1007/s12079-013-0190-x. Epub 2013 Jan 20. J Cell Commun Signal. 2013. PMID: 23334556 Free PMC article.
-
Bronchopulmonary Dysplasia: Crosstalk Between PPARγ, WNT/β-Catenin and TGF-β Pathways; The Potential Therapeutic Role of PPARγ Agonists.Front Pediatr. 2019 May 3;7:176. doi: 10.3389/fped.2019.00176. eCollection 2019. Front Pediatr. 2019. PMID: 31131268 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical